0.8879
price up icon4.01%   0.0342
after-market アフターアワーズ: .85 -0.0379 -4.27%
loading

Jaguar Health Inc (JAGX) 最新ニュース

pulisher
Feb 25, 2026

Is Jaguar Health Inc stock showing strong momentumJuly 2025 Action & Real-Time Sentiment Analysis - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 24, 2026

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - The Coloradoan

Feb 24, 2026
pulisher
Feb 24, 2026

JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026
pulisher
Feb 20, 2026

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - 富途牛牛

Feb 20, 2026
pulisher
Feb 18, 2026

Jaguar Health (JAGX) Announces Special Stock Dividend with Conve - GuruFocus

Feb 18, 2026
pulisher
Feb 18, 2026

Jaguar Declares Special Stock Dividend to Protect Shareholders - Intellectia AI

Feb 18, 2026
pulisher
Feb 18, 2026

Jaguar Health Declares Special Convertible Preferred Stock Dividend - TipRanks

Feb 18, 2026
pulisher
Feb 18, 2026

Jaguar Health to Pay Special Stock Dividend - marketscreener.com

Feb 18, 2026
pulisher
Feb 18, 2026

Jaguar Health Announces a Special One-time Stock Dividend - ACCESS Newswire

Feb 18, 2026
pulisher
Feb 16, 2026

Hedge Fund Moves: Should value investors consider Jaguar Health IncJuly 2025 Volume & AI Driven Stock Price Forecasts - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 16, 2026

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Treasure Coast News

Feb 16, 2026
pulisher
Feb 16, 2026

Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas - ACCESS Newswire

Feb 16, 2026
pulisher
Feb 15, 2026

Is Jaguar Health Inc. stock a safe buy before earningsQuarterly Investment Review & AI Based Trade Execution Alerts - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Will Jaguar Health Inc. benefit from current market trendsGap Up & Low Risk Investment Opportunities - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Bull Bear: Is Howard Hughes Holdings Inc a cyclical or defensive stockJuly 2025 Final Week & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 13, 2026

Is Jaguar Health Inc. undervalued by DCF analysisWeekly Trade Summary & High Win Rate Trade Tips - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Is Jaguar Health Inc. stock showing strong momentum2025 Big Picture & Weekly High Return Stock Opportunities - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY - TradingView

Feb 12, 2026
pulisher
Feb 09, 2026

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million - Marco Eagle

Feb 09, 2026
pulisher
Feb 05, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Feb 05, 2026
pulisher
Jan 31, 2026

Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts - The Marion Star

Jan 31, 2026
pulisher
Jan 29, 2026

Should value investors consider Jaguar Health Inc.July 2025 Opening Moves & Weekly Breakout Watchlists - mfd.ru

Jan 29, 2026
pulisher
Jan 28, 2026

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - hattiesburgamerican.com

Jan 28, 2026
pulisher
Jan 26, 2026

Jaguar Health Executes Debt-Reducing Equity Warrant Transactions - TipRanks

Jan 26, 2026
pulisher
Jan 23, 2026

Jaguar Health Signs Multiple Material Agreements - TradingView

Jan 23, 2026
pulisher
Jan 22, 2026

Jaguar Health (JAGX) Advances Rare Disease Program with Focus on Crofelemer - GuruFocus

Jan 22, 2026
pulisher
Jan 22, 2026

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi - Lansing State Journal

Jan 22, 2026
pulisher
Jan 22, 2026

Jaguar trial cuts children’s IV support needs by up to 37% - Stock Titan

Jan 22, 2026
pulisher
Jan 22, 2026

Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - barnstablepatriot.com

Jan 22, 2026
pulisher
Jan 19, 2026

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Pueblo Chieftain

Jan 19, 2026
pulisher
Jan 19, 2026

Earnings Report: Is Jaguar Health Inc a defensive stock2025 Valuation Update & Scalable Portfolio Growth Ideas - baoquankhu1.vn

Jan 19, 2026
$101.27
price up icon 1.18%
$28.94
price up icon 1.58%
$53.57
price up icon 3.60%
$110.23
price up icon 1.31%
$149.33
price down icon 0.45%
biotechnology ONC
$316.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):